ASNC, ACC Ask U.S. Government to Defer Tariffs on Radiopharmaceuticals

Last week, ASNC and the American College of Cardiology (ACC) submitted joint comments urging deferral of tariffs on radiopharmaceuticals until domestic sources are established. The organizations’ comments were in response to an inquiry from the Department of Commerce after its launch of a section 232 investigation aimed at determining the effects on national security of importing pharmaceuticals and pharmaceutical ingredients.

In their comments letter, ASNC and ACC explain that development of a domestic supply of molybdenum-99 has been a priority for many years, as evidenced by passage of the American Medical Isotope Production Act of 2012. Despite many years of effort, the U.S. does not have a domestic supply of Mo-99 and is still working toward that goal.

After the investigation, the Commerce Department will present its findings and recommendations to President Trump. For updates, stay tuned to ASNC.

ASNC/ACC Comments